Last update 08 May 2025

Live attenuated tetravalent dengue (DEN) vaccine(GSK)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Multivalent vaccine
Synonyms-
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious Diseases
Active Indication-
Inactive Indication
Dengue
Originator Organization
GSK PlcGSK Plc
Active Organization-
Inactive Organization
GSK PlcGSK Plc
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Live attenuated tetravalent dengue (DEN) vaccine(GSK)
NCT00239577
/ CompletedPhase 2
Observer-blind, Single Center, Controlled Study of 2 Doses of Various Formulations of the WRAIR Live Attenuated Tetravalent Dengue Vaccine Compared to a Placebo Control, Administered on a 0-6-month Schedule, to Healthy Adults
NCT01843621
/ CompletedPhase 1/2IIT
A Phase I/II, Open, Five-year, Clinical Follow-up Study of Thai Children Who Participated in Dengue-003 ("A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children") With Evaluation of a Booster Dose Given One Year After Primary DEN Vaccination Series
100 Clinical Results associated with Live attenuated tetravalent dengue (DEN) vaccine(GSK)
Login to view more data
100 Translational Medicine associated with Live attenuated tetravalent dengue (DEN) vaccine(GSK)
Login to view more data
100 Patents (Medical) associated with Live attenuated tetravalent dengue (DEN) vaccine(GSK)
Login to view more data
100 Deals associated with Live attenuated tetravalent dengue (DEN) vaccine(GSK)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
DenguePhase 2
United States
GSK PlcGSK Plc
05 Apr 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT00239577 (CTgov)
Phase 2
Dengue
86
(Dengue Formulation 17a Group)
(pjrcoysjoe) = fizqelnzly dvkjrompmh (csoaayxzjs, drqnaktypv - vbshrsvmkl)
View more
-
19 Feb 2019
(Dengue Formulation 17b Group)
(pjrcoysjoe) = xdghnajfcv dvkjrompmh (csoaayxzjs, ylyguxjfnd - pbmknvkdfr)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free